Home

Allurion Technologies, Inc. Common Stock (ALUR)

2.5100
-0.0700 (-2.71%)
NYSE · Last Trade: Aug 13th, 3:29 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close2.580
Open2.500
Bid2.490
Ask2.520
Day's Range2.300 - 2.648
52 Week Range2.150 - 22.25
Volume106,700
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume79,476

Chart

News & Press Releases

Allurion Revenue Drops 71 Percent in Q2fool.com
Via The Motley Fool · August 13, 2025
Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the second quarter and provided a business update.
By Allurion Technologies, Inc. · Via Business Wire · August 13, 2025
Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that it will report financial results for the second quarter 2025 on Wednesday, August 13, 2025. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET.
By Allurion Technologies, Inc. · Via Business Wire · August 7, 2025
Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a new strategic direction with an increasing focus on low-dose GLP-1 combination therapy, muscle mass maintenance, and US market entry.
By Allurion Technologies, Inc. · Via Business Wire · August 5, 2025
Earnings Scheduled For August 13, 2025benzinga.com
Via Benzinga · August 13, 2025
Preview: Allurion Technologies's Earningsbenzinga.com
Via Benzinga · August 12, 2025
Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced new publications on long-term weight loss results with the Allurion Program.
By Allurion Technologies, Inc. · Via Business Wire · July 22, 2025
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · July 15, 2025
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · July 9, 2025
What's going on in today's after hours sessionchartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · July 9, 2025
Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with Minogue Medical Inc., a leading Canadian medical device company specializing in bariatric and obesity care. This new partnership draws upon Minogue Medical’s 40-year experience in the Canadian market and reflects Allurion’s commitment to establishing a new standard of care in obesity management focused on metabolically healthy weight loss.
By Allurion Technologies, Inc. · Via Business Wire · July 9, 2025
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 7, 2025
Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced submission of the fourth and final module of the Pre-Market Approval (PMA) application to the Food & Drug Administration (FDA) and additional, supportive analyses from the AUDACITY Study that meet both of the pre-specified co-primary endpoints.
By Allurion Technologies, Inc. · Via Business Wire · July 7, 2025
Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today presented two new abstracts at the American Society for Metabolic & Bariatric Surgery (ASMBS) 2025 Annual Meeting.
By Allurion Technologies, Inc. · Via Business Wire · June 17, 2025
Allurion to Present at Jefferies Global Healthcare Conference
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gaur, Founder and Chief Executive Officer, will present at the upcoming Jefferies Global Healthcare Conference in New York. The live presentation will take place on Wednesday, June 4 at 3:45 p.m. ET.
By Allurion Technologies, Inc. · Via Business Wire · May 29, 2025
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 28, 2025
10 Consumer Discretionary Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · May 27, 2025
Get insights into the top gainers and losers of Tuesday's after-hours session.chartmill.com
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · May 27, 2025
Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the presentation of a study at the Societe Francaise et Francophone de Chiurgie de l’Obesite et des Maladies Metaboliques (SOFFCO.MM) meeting in Saint-Etienne, France, May 22-23, 2025.
By Allurion Technologies, Inc. · Via Business Wire · May 27, 2025
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 22, 2025
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · May 21, 2025
Money Movers: HIT, SEPN, ALUR, LUCY, PRSO – Biotech, Healthcare, AI & Weight Loss Innovators Lead Momentum Surge – More Stocks Inside
Today’s pre-market spotlight highlights a powerful mix of emerging growth companies driving innovation across key sectors including AI-powered Insurtech, mmWave wireless connectivity, smart wearables, clinical-stage biotech, and advanced weight loss solutions. From Health In Tech’s (NASDAQ: HIT) disruptive insurance platform to Peraso’s (NASDAQ: PRSO) wireless technology milestone, Allurion’s (NASDAQ: ALUR) FDA-ready program, Septerna’s (NYSE: SEPN) GPCR-based therapeutics, Quoin’s (NASDAQ: QNRX) progress in rare skin disease treatment and Innovative Eyewear’s (NASDAQ: LUCY) Smart Branded eyewear, these companies represent pivotal trends shaping the market in 2025. As investors seek early exposure to transformative technologies, these pre-market movers warrant close attention.
Via AB Newswire · May 14, 2025
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 14, 2025
Wednesday's pre-market session: top gainers and loserschartmill.com
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · May 14, 2025
Allurion Reports First Quarter 2025 Financial Results and Provides Business Update
Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a pioneer in metabolically healthy weight loss, today announced its financial results for the first quarter and provided a business update.
By Allurion Technologies, Inc. · Via Business Wire · May 14, 2025